JPH0254351B2 - - Google Patents
Info
- Publication number
- JPH0254351B2 JPH0254351B2 JP4090382A JP4090382A JPH0254351B2 JP H0254351 B2 JPH0254351 B2 JP H0254351B2 JP 4090382 A JP4090382 A JP 4090382A JP 4090382 A JP4090382 A JP 4090382A JP H0254351 B2 JPH0254351 B2 JP H0254351B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- solvent
- epidioxy
- diene
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- IICCLYANAQEHCI-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 IICCLYANAQEHCI-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229930187593 rose bengal Natural products 0.000 description 3
- 229940081623 rose bengal Drugs 0.000 description 3
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BJYLYJCXYAMOFT-RRXOBRNQSA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-1-[(2r)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCC(O)C(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C BJYLYJCXYAMOFT-RRXOBRNQSA-N 0.000 description 1
- SNOXQOOPUCMFPS-IBLPRGGXSA-N (1s,3z)-3-[(2e)-2-[(1r,3as,7ar)-1-[(2r,5r)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CC[C@@H](O)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C SNOXQOOPUCMFPS-IBLPRGGXSA-N 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- QKGYJVXSKCDGOK-UHFFFAOYSA-N hexane;propan-2-ol Chemical compound CC(C)O.CCCCCC QKGYJVXSKCDGOK-UHFFFAOYSA-N 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000002165 photosensitisation Effects 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4090382A JPS58159487A (ja) | 1982-03-17 | 1982-03-17 | 新規なビタミンｄ３誘導体 |
| CA000416816A CA1191858A (en) | 1981-12-08 | 1982-12-01 | Vitamin d.sub.3 derivatives and process for producing the same |
| DE8282111302T DE3270501D1 (en) | 1981-12-08 | 1982-12-07 | Novel vitamin d3 derivatives and process for producing the same |
| AT82111302T ATE19076T1 (de) | 1981-12-08 | 1982-12-07 | Vitamin d3 derivate und verfahren zu ihrer herstellung. |
| EP19820111302 EP0081793B1 (en) | 1981-12-08 | 1982-12-07 | Novel vitamin d3 derivatives and process for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4090382A JPS58159487A (ja) | 1982-03-17 | 1982-03-17 | 新規なビタミンｄ３誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58159487A JPS58159487A (ja) | 1983-09-21 |
| JPH0254351B2 true JPH0254351B2 (es) | 1990-11-21 |
Family
ID=12593462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4090382A Granted JPS58159487A (ja) | 1981-12-08 | 1982-03-17 | 新規なビタミンｄ３誘導体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58159487A (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0473654U (es) * | 1990-11-05 | 1992-06-29 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6298500U (es) * | 1985-12-06 | 1987-06-23 |
-
1982
- 1982-03-17 JP JP4090382A patent/JPS58159487A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0473654U (es) * | 1990-11-05 | 1992-06-29 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58159487A (ja) | 1983-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jones et al. | Isolation and identification of 1, 25-dihydroxyvitamin D2 | |
| Nickon et al. | Reactivity and geometry in allylic systems. I. Stereochemistry of photosensitized oxygenation of monoölefins1, 2 | |
| GB2142922A (en) | Steroid intermediates in the synthesis of-hydroxyvitamin d2 | |
| Kutner et al. | Novel convergent synthesis of side-chain-modified analogs of 1. alpha., 25-dihydroxycholecalciferol and 1. alpha., 25-dihydroxyergocalciferol | |
| KR900008120B1 (ko) | 비타민 d₃유도체의 제조방법 | |
| Lam et al. | 24, 25-Dihydroxyvitamin D3. Synthesis and biological activity | |
| Paquette et al. | Synthetic studies on basmane diterpenes. Enantiospecific total synthesis of (+)-7, 8-epoxy-2-basmen-6-one by Claisen ring expansion | |
| Burrows et al. | Reassignment of configuration to the 22-hydroxycholesterols. Synthesis of (22S)-and (22R)-3H-cholesterols | |
| RO120338B1 (ro) | Derivaţi analogi ai vitaminei d | |
| JPH0254351B2 (es) | ||
| Tsuji et al. | A new and convenient synthesis of 1. ALPHA., 25-dihydroxyvitamin D2 and its 24R-epimer. | |
| US4397847A (en) | Method of treatment | |
| US4021423A (en) | Syntheses of 24R,25- and 24S,25-dihydroxycholecalciferol | |
| SATO et al. | Chemistry of the Spiroaminoketal Side Chain of Solasodine and Tomatidine. V. 1 The Synthesis of the Isomeric Solanidanones | |
| JPH02504149A (ja) | １α―ヒドロキシビタミンＤ同族体 | |
| Caine et al. | Influence of substituents on the photochemical behavior of cross-conjugated cyclohexadienones. Facile total synthesis of (-)-cyclocolorenone | |
| PT96679B (pt) | Processo para a preparacao de derivados de vitamina d homologos de cadeias laterais e de composicoes farmaceuticas que os contem | |
| Cordall et al. | Structure elucidation and chemistry of Catharanthus alkaloids. XXX. Isolation and structure elucidation of vincarodine | |
| Dayal et al. | Configurational assignment of 5β-cholestane-3α, 7α, 12α, 23, 25-pentol excreted by patients with cerebrotendinous xanthomatosis (a circular dichroism study) | |
| JPS62502545A (ja) | セコステロール化合物 | |
| Russell et al. | Application of electron spin resonance spectroscopy to problems of structure and conformation. XXIV. Aliphatic semidiones. XIX. Polycyclic derivatives of cyclobutanesemidione | |
| Lieberman et al. | ▵ 5-Cholestene-3β, 4β, 7α-triol and the Inhibition of the Oxidation of Hydroxyl Groups by Vicinal Substituents | |
| JPS61233618A (ja) | 液体状１α−ヒドロキシビタミンＤ組成物の製造法 | |
| Kirk et al. | Synthesis of [26, 27-2 H 6] cholesterol and derivatives substituted in the side chain | |
| TSUDA et al. | Lycopodium triterpenoids.(7). The Structures and partial syntheses of 16-oxoserratenediol, 16-oxo-21-episerratenediol, 16-oxodiepiserratenediol, 16-oxoserratriol, 16-oxo-21-episerratriol, and 16-oxolycoclavanol, α, β-unsaturated Ketones of serratane group |